Analysis

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) and Its Biotechnology Sector Peers: A Comparative Analysis

10/09/2024

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) and Its Biotechnology Sector Peers: A Comparative Analysis

10/09/2024

News

New Strong Sell Stocks for July 31st

CELZ, GRFS and WHR have been added to the Zacks Rank #5 (Strong Sell) List on July 31, 2025.

07/31/2025

Creative Medical Technology Holdings Receives Notice of Allowance for the Prevention and/or Treatment of Type 1 Diabetes Using Modulated Immune Cells

PHOENIX, July 17, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company specializing in regenerative medicine, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a U.S. patent application titled, “Prevention and/or Treatment of Type 1 Diabetes by Augmentation of Myeloid Suppressor Cell Activity.”

07/17/2025

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is Creative Medical Technology Holdings, Inc. (CELZ) a buy, sell, or hold?

Creative Medical Technology Holdings, Inc. (CELZ) can sell. Click on Rating Page for detail.

What is Creative Medical Technology Holdings, Inc.'s stock price?

The price of Creative Medical Technology Holdings, Inc. (CELZ) is 3.25 and it was updated on 2025-10-02 11:00:26.

Is Creative Medical Technology Holdings, Inc. (CELZ) overvalued or undervalued?

Currently Creative Medical Technology Holdings, Inc. (CELZ) is in undervalued.

News

From:

To:

News
Creative Medical Technology Holdings Receives Notice of Allowance for ImmCelz™ for Treatment of Heart Failure and/or Post Infarct Pathological Remodeling PHOENIX, July 11, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical” or the “Company”), a clinical-stage biotechnology company specializing in regenerative medicine, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a U.S. patent application titled, “Treatment Of Heart Failure And/Or Post Infarct Pathological Remodeling By Ex Vivo Reprogrammed Immune Cells.” Fri, Jul. 11, 2025
Creative Medical Technology Holdings, Inc. (CELZ) Upgraded to Buy: What Does It Mean for the Stock? Creative Medical Technology Holdings, Inc. (CELZ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Tue, Mar. 25, 2025
Is Creative Medical Technology Holdings, Inc. (CELZ) Stock Outpacing Its Medical Peers This Year? Here is how Creative Medical Technology Holdings, Inc. (CELZ) and 89BIO (ETNB) have performed compared to their sector so far this year. Tue, Mar. 25, 2025
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain Positive Interim Blinded Data Supports Advancement Toward Potential Pivotal Phase 3 Study Positive Interim Blinded Data Supports Advancement Toward Potential Pivotal Phase 3 Study Thu, Mar. 20, 2025
Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds PHOENIX, March 06, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc., (Nasdaq: CELZ) (the “Company”), a leading biotechnology innovator in regenerative medicine, today announced it has entered into agreements with certain holders of its existing warrants for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 837,104 shares of common stock of the Company originally issued in October 2024 at their current exercise price of $4.42 per share. The shares of common stock issuable upon exercise of the existing warrants are registered pursuant to an effective registration statement on Form S-1 (File No. 333-283091). The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $3.7 million, before deducting financial advisory fees. Thu, Mar. 06, 2025

SEC Filings

SEC Filings
Creative Medical Technology Holdings, Inc. (CELZ) - SCHEDULE 13G/A SEC Filings 08/14/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/08/2025
Creative Medical Technology Holdings, Inc. (CELZ) - SCHEDULE 13G SEC Filings 05/15/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/09/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 05/06/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K/A - Current report SEC Filings 04/25/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 424B3 SEC Filings 04/15/2025
Creative Medical Technology Holdings, Inc. (CELZ) - EFFECT SEC Filings 04/14/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 04/11/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K/A - Current report SEC Filings 04/04/2025
Creative Medical Technology Holdings, Inc. (CELZ) - S-3 SEC Filings 04/02/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K/A - Current report SEC Filings 03/19/2025
Creative Medical Technology Holdings, Inc. (CELZ) - DEF 14A SEC Filings 03/17/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 03/14/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 03/14/2025
Creative Medical Technology Holdings, Inc. (CELZ) - PRE 14A SEC Filings 03/07/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 03/07/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 02/20/2025
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 12/26/2024
Creative Medical Technology Holdings, Inc. (CELZ) - EFFECT SEC Filings 11/20/2024
Creative Medical Technology Holdings, Inc. (CELZ) - 424B3 SEC Filings 11/20/2024
Creative Medical Technology Holdings, Inc. (CELZ) - S-1 SEC Filings 11/08/2024
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/08/2024
Creative Medical Technology Holdings, Inc. (CELZ) - DEF 14A SEC Filings 11/04/2024
Creative Medical Technology Holdings, Inc. (CELZ) - PRER14A SEC Filings 10/23/2024
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 10/23/2024
Creative Medical Technology Holdings, Inc. (CELZ) - 424B5 SEC Filings 10/23/2024
Creative Medical Technology Holdings, Inc. (CELZ) - EFFECT SEC Filings 10/16/2024
Creative Medical Technology Holdings, Inc. (CELZ) - S-3 SEC Filings 10/04/2024
Creative Medical Technology Holdings, Inc. (CELZ) - PRE 14A SEC Filings 10/04/2024
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/09/2024
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 07/25/2024
Creative Medical Technology Holdings, Inc. (CELZ) - DEF 14A SEC Filings 06/05/2024
Creative Medical Technology Holdings, Inc. (CELZ) - PRE 14A SEC Filings 05/17/2024
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 05/17/2024
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/10/2024
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K/A - Current report SEC Filings 04/29/2024
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 03/22/2024
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 12/20/2023
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/14/2023
Creative Medical Technology Holdings, Inc. (CELZ) - DEF 14A SEC Filings 11/03/2023
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/11/2023
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 06/29/2023
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 06/28/2023
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 06/09/2023
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13G/A SEC Filings 05/26/2023
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/12/2023
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13G SEC Filings 05/02/2023
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K/A - Current report SEC Filings 05/01/2023
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 03/31/2023
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 12/19/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 11/23/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/10/2022
Creative Medical Technology Holdings, Inc. (CELZ) - DEF 14A SEC Filings 10/26/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 09/29/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 09/28/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 09/22/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/12/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 07/14/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 06/14/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 06/07/2022
Creative Medical Technology Holdings, Inc. (CELZ) - EFFECT SEC Filings 05/20/2022
Creative Medical Technology Holdings, Inc. (CELZ) - EFFECT SEC Filings 05/20/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 424B3 SEC Filings 05/20/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 05/20/2022
Creative Medical Technology Holdings, Inc. (CELZ) - CORRESP SEC Filings 05/17/2022
Creative Medical Technology Holdings, Inc. (CELZ) - UPLOAD SEC Filings 05/16/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/13/2022
Creative Medical Technology Holdings, Inc. (CELZ) - S-3 SEC Filings 05/10/2022
Creative Medical Technology Holdings, Inc. (CELZ) - D SEC Filings 05/05/2022
Creative Medical Technology Holdings, Inc. (CELZ) - RW SEC Filings 05/04/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 05/04/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K/A - Current report SEC Filings 04/29/2022
Creative Medical Technology Holdings, Inc. (CELZ) - S-1 SEC Filings 04/22/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 03/30/2022
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13G/A SEC Filings 02/14/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 02/11/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 02/11/2022
Creative Medical Technology Holdings, Inc. (CELZ) - 3 SEC Filings 01/05/2022
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13G SEC Filings 12/20/2021
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13G SEC Filings 12/17/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 3 SEC Filings 12/13/2021
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13G SEC Filings 12/10/2021
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13G SEC Filings 12/08/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 12/07/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 424B4 SEC Filings 12/06/2021
Creative Medical Technology Holdings, Inc. (CELZ) - EFFECT SEC Filings 12/03/2021
Creative Medical Technology Holdings, Inc. (CELZ) - EFFECT SEC Filings 12/03/2021
Creative Medical Technology Holdings, Inc. (CELZ) - UPLOAD SEC Filings 12/02/2021
Creative Medical Technology Holdings, Inc. (CELZ) - S-1/A SEC Filings 12/02/2021
Creative Medical Technology Holdings, Inc. (CELZ) - CORRESP SEC Filings 12/02/2021
Creative Medical Technology Holdings, Inc. (CELZ) - CERT SEC Filings 12/02/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-A12B SEC Filings 12/02/2021
Creative Medical Technology Holdings, Inc. (CELZ) - S-1/A SEC Filings 12/01/2021
Creative Medical Technology Holdings, Inc. (CELZ) - CORRESP SEC Filings 11/30/2021
Creative Medical Technology Holdings, Inc. (CELZ) - S-1/A SEC Filings 11/23/2021
Creative Medical Technology Holdings, Inc. (CELZ) - CORRESP SEC Filings 11/23/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/15/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 11/09/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 11/05/2021
Creative Medical Technology Holdings, Inc. (CELZ) - UPLOAD SEC Filings 10/07/2021
Creative Medical Technology Holdings, Inc. (CELZ) - S-1 SEC Filings 09/28/2021
Creative Medical Technology Holdings, Inc. (CELZ) - S-1 SEC Filings 09/27/2021
Creative Medical Technology Holdings, Inc. (CELZ) - DEF 14C SEC Filings 09/24/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 09/22/2021
Creative Medical Technology Holdings, Inc. (CELZ) - PRE 14C SEC Filings 09/07/2021
Creative Medical Technology Holdings, Inc. (CELZ) - D SEC Filings 08/27/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/16/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 08/12/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 07/22/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 07/16/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 06/29/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/17/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 04/02/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 03/25/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 03/17/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 03/12/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 03/05/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K/A - Current report SEC Filings 02/22/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 02/22/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 02/18/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 02/12/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 02/08/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 01/14/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 01/08/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 01/04/2021
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 12/31/2020
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/13/2020
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 10/02/2020
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/14/2020
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 06/05/2020
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/15/2020
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 04/06/2020
Creative Medical Technology Holdings, Inc. (CELZ) - NT 10-K - Current report SEC Filings 03/30/2020
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 03/24/2020
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 02/19/2020
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 01/31/2020
Creative Medical Technology Holdings, Inc. (CELZ) - DEFR14C SEC Filings 01/03/2020
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 12/13/2019
Creative Medical Technology Holdings, Inc. (CELZ) - DEF 14C SEC Filings 11/22/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/14/2019
Creative Medical Technology Holdings, Inc. (CELZ) - PRE 14C SEC Filings 11/05/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 11/05/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 10/16/2019
Creative Medical Technology Holdings, Inc. (CELZ) - DEF 14C SEC Filings 09/13/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 09/09/2019
Creative Medical Technology Holdings, Inc. (CELZ) - PRE 14C SEC Filings 08/30/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/13/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 07/31/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 07/08/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 07/03/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K/A - Current report SEC Filings 06/28/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 06/24/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K/A - Current report SEC Filings 06/20/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/20/2019
Creative Medical Technology Holdings, Inc. (CELZ) - NT 10-Q - Quarterly Report SEC Filings 05/15/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 05/08/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 04/02/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 04/01/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 03/05/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 02/19/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 01/02/2019
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 11/23/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/14/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 11/06/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 10/22/2018
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13D/A SEC Filings 10/18/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 10/18/2018
Creative Medical Technology Holdings, Inc. (CELZ) - D SEC Filings 09/28/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 09/27/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 08/31/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 08/16/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 08/14/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/14/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q/A - Quarterly Report SEC Filings 08/03/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 07/24/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 07/12/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 06/21/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 06/07/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/21/2018
Creative Medical Technology Holdings, Inc. (CELZ) - NT 10-Q - Quarterly Report SEC Filings 05/14/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 05/10/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 04/30/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 04/27/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 04/23/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 04/17/2018
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13D/A SEC Filings 04/13/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 04/13/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 04/13/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 03/29/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 03/29/2018
Creative Medical Technology Holdings, Inc. (CELZ) - D SEC Filings 03/27/2018
Creative Medical Technology Holdings, Inc. (CELZ) - D SEC Filings 03/02/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 03/02/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 02/23/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 02/01/2018
Creative Medical Technology Holdings, Inc. (CELZ) - UPLOAD SEC Filings 01/31/2018
Creative Medical Technology Holdings, Inc. (CELZ) - DEF 14C SEC Filings 01/31/2018
Creative Medical Technology Holdings, Inc. (CELZ) - CORRESP SEC Filings 01/30/2018
Creative Medical Technology Holdings, Inc. (CELZ) - PRER14C SEC Filings 01/23/2018
Creative Medical Technology Holdings, Inc. (CELZ) - CORRESP SEC Filings 01/23/2018
Creative Medical Technology Holdings, Inc. (CELZ) - UPLOAD SEC Filings 01/19/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 01/16/2018
Creative Medical Technology Holdings, Inc. (CELZ) - PRE 14C SEC Filings 01/12/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 01/12/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 01/04/2018
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 12/20/2017
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13G/A SEC Filings 12/18/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 12/18/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 12/13/2017
Creative Medical Technology Holdings, Inc. (CELZ) - D SEC Filings 12/08/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 11/17/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 11/16/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/13/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 10/18/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 10/12/2017
Creative Medical Technology Holdings, Inc. (CELZ) - D SEC Filings 09/06/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 08/31/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 08/28/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/14/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 07/25/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 06/21/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 144 SEC Filings 06/12/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 06/07/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 06/07/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 06/05/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 05/24/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 05/19/2017
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13D/A SEC Filings 05/18/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 05/18/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 144 SEC Filings 05/12/2017
Creative Medical Technology Holdings, Inc. (CELZ) - D SEC Filings 05/11/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/10/2017
Creative Medical Technology Holdings, Inc. (CELZ) - D SEC Filings 05/08/2017
Creative Medical Technology Holdings, Inc. (CELZ) - D SEC Filings 04/17/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 04/04/2017
Creative Medical Technology Holdings, Inc. (CELZ) - D SEC Filings 03/28/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 03/08/2017
Creative Medical Technology Holdings, Inc. (CELZ) - EFFECT SEC Filings 03/06/2017
Creative Medical Technology Holdings, Inc. (CELZ) - CT ORDER SEC Filings 03/02/2017
Creative Medical Technology Holdings, Inc. (CELZ) - POS AM SEC Filings 02/22/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 02/22/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 02/13/2017
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13D/A SEC Filings 02/06/2017
Creative Medical Technology Holdings, Inc. (CELZ) - UPLOAD SEC Filings 02/03/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 01/27/2017
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13G SEC Filings 01/17/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 4/A SEC Filings 01/06/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 01/04/2017
Creative Medical Technology Holdings, Inc. (CELZ) - 424B3 SEC Filings 12/14/2016
Creative Medical Technology Holdings, Inc. (CELZ) - EFFECT SEC Filings 12/13/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 12/13/2016
Creative Medical Technology Holdings, Inc. (CELZ) - CORRESP SEC Filings 12/08/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 12/06/2016
Creative Medical Technology Holdings, Inc. (CELZ) - S-1 SEC Filings 11/21/2016
Creative Medical Technology Holdings, Inc. (CELZ) - CORRESP SEC Filings 11/21/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 11/16/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 11/14/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/10/2016
Creative Medical Technology Holdings, Inc. (CELZ) - UPLOAD SEC Filings 11/03/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 11/02/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 11/01/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 3/A SEC Filings 10/26/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 3/A SEC Filings 10/24/2016
Creative Medical Technology Holdings, Inc. (CELZ) - DRS/A SEC Filings 10/12/2016
Creative Medical Technology Holdings, Inc. (CELZ) - UPLOAD SEC Filings 10/03/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 09/15/2016
Creative Medical Technology Holdings, Inc. (CELZ) - DRSLTR SEC Filings 09/01/2016
Creative Medical Technology Holdings, Inc. (CELZ) - DRS/A SEC Filings 09/01/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 08/31/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 08/24/2016
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13G SEC Filings 08/23/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 3 SEC Filings 08/23/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/19/2016
Creative Medical Technology Holdings, Inc. (CELZ) - NT 10-Q - Quarterly Report SEC Filings 08/15/2016
Creative Medical Technology Holdings, Inc. (CELZ) - UPLOAD SEC Filings 07/01/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 06/21/2016
Creative Medical Technology Holdings, Inc. (CELZ) - DRS SEC Filings 06/20/2016
Creative Medical Technology Holdings, Inc. (CELZ) - SC 13D SEC Filings 06/06/2016
Creative Medical Technology Holdings, Inc. (CELZ) - D SEC Filings 05/23/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 3 SEC Filings 05/20/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 05/19/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 4 SEC Filings 05/19/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/13/2016
Creative Medical Technology Holdings, Inc. (CELZ) - SC 14F1 SEC Filings 05/05/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 05/05/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 04/14/2016
Creative Medical Technology Holdings, Inc. (CELZ) - NT 10-K - Current report SEC Filings 03/30/2016
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/09/2015
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 09/30/2015
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/13/2015
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 07/21/2015
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/08/2015
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 02/27/2015
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/12/2014
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/08/2014
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/13/2014
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 03/17/2014
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/13/2013
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q/A - Quarterly Report SEC Filings 09/18/2013
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/07/2013
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q/A - Quarterly Report SEC Filings 05/24/2013
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/07/2013
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 03/15/2013
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 11/07/2012
Creative Medical Technology Holdings, Inc. (CELZ) - UPLOAD SEC Filings 08/21/2012
Creative Medical Technology Holdings, Inc. (CELZ) - CORRESP SEC Filings 08/17/2012
Creative Medical Technology Holdings, Inc. (CELZ) - CORRESP SEC Filings 08/16/2012
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K/A - Current report SEC Filings 08/16/2012
Creative Medical Technology Holdings, Inc. (CELZ) - UPLOAD SEC Filings 08/15/2012
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 08/13/2012
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/09/2012
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/11/2012
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 03/26/2012
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 10/31/2011
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q/A - Quarterly Report SEC Filings 08/25/2011
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q/A - Quarterly Report SEC Filings 08/24/2011
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/15/2011
Creative Medical Technology Holdings, Inc. (CELZ) - DEF 14C SEC Filings 06/21/2011
Creative Medical Technology Holdings, Inc. (CELZ) - PRE 14C SEC Filings 06/09/2011
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/16/2011
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 03/31/2011
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 10/19/2010
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/12/2010
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/07/2010
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 02/03/2010
Creative Medical Technology Holdings, Inc. (CELZ) - 8-K - Current report SEC Filings 12/22/2009
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 10/08/2009
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 08/06/2009
Creative Medical Technology Holdings, Inc. (CELZ) - 10-Q - Quarterly Report SEC Filings 05/15/2009
Creative Medical Technology Holdings, Inc. (CELZ) - 10-K - Current report SEC Filings 05/14/2009
Creative Medical Technology Holdings, Inc. (CELZ) - 3 SEC Filings 01/28/2009
Creative Medical Technology Holdings, Inc. (CELZ) - 10-12G SEC Filings 11/18/2008
Creative Medical Technology Holdings, Inc. (CELZ) - RW SEC Filings 11/07/2008
Creative Medical Technology Holdings, Inc. (CELZ) - S-1 SEC Filings 11/05/2008
Creative Medical Technology Holdings, Inc. (CELZ) - REGDEX SEC Filings 08/11/2008
Creative Medical Technology Holdings, Inc. (CELZ) - RW SEC Filings 11/19/2002
Creative Medical Technology Holdings, Inc. (CELZ) - SB-2 SEC Filings 09/13/2002

Press Releases

StockPrice Release
Creative medical technology holdings receives notice of allowance for the prevention and/or treatment of type 1 diabetes using modulated immune cells 07/17/2025
Creative medical technology holdings receives notice of allowance for immcelz™ for treatment of heart failure and/or post infarct pathological remodeling 07/11/2025
Creative medical technology holdings secures fda clearance for expanded dose escalation in the clinical trial of celz-201-ddt for chronic lower back pain 03/20/2025
Creative medical technology holdings announces agreements for exercise of warrants for $3.7 million gross proceeds 03/06/2025
Creative medical technology holdings announces mid-term follow-up study data reporting significant reduction in opioid use by chronic lower back pain patients undergoing stemspine® procedure using allostem™ 02/14/2025
Creative medical technology reports positive one-year results for allostem™ type 2 diabetes program 02/11/2025
Creative medical technology holdings expands collaboration with greenstone biosciences to accelerate ipscelz pipeline development 02/05/2025
Creative medical technology holdings announces positive initial safety, tolerability, and efficacy data from first cohort in phase 1/2 trial of celz-201-ddt for chronic back pain 01/30/2025
Creative medical technology holdings, inc. advances fda cleared adapt clinical trial with positive independent review, validating the safety and potential of celz-201 for chronic lower back pain treatment 11/13/2024
Creative medical technology holdings initiates development of ai-driven diagnostic and treatment program for biologic and chemical exposure utilizing its validated ipsc personalized medicine program 07/24/2024
Creative medical technology holdings provides corporate update 07/10/2024
Creative medical technology holdings announces evolutionary development of its ipscelz® program with the successful generation of ipsc derived islet cells that produce human insulin 06/24/2024
Creative medical technology holdings provides corporate update 03/27/2024
Creative medical technology holdings inc. announces fda authorization for groundbreaking type 1 diabetes prevention therapy under expanded access 03/07/2024
Creative medical technology holdings, inc. receives fda orphan drug designation for celz-101 in key transplantation therapy 03/06/2024
Creative medical technology granted fda clearance for chronic back pain clinical trial 12/21/2023
Creative medical technology holdings (nasdaq:celz) granted fda clearance to begin phase 1/2 clinical trial of allostem(tm) for addressing chronic lower back pain 12/20/2023
Creative medical technology holdings provides corporate update 11/15/2023
Creative medical technology holdings announces irb approval for fda cleared phase 1/2 clinical trial of stemspine® using allostem™ ("celz-201-ddt") novel cell therapy to treat chronic lower back pain 10/10/2023
Creative medical technology holdings receives fda clearance to initiate a phase 1/2 clinical trial of stemspine® using allostem™ (celz-201-ddt) for the treatment of chronic lower back pain 09/19/2023
What is allogeneic cell therapy, and what's driving this market's 25%+ annual global growth? 08/24/2023
The immunotherapy market is expected to surpass $351.56 billion by 2030 - creative medical technology holdings, inc. (nasdaq:celz) is contributing to this growth 07/14/2023
Creative medical technology reports advancements in regenerative medicine and improvements in financial position in corporate update 07/13/2023
Creative medical technology holdings regains compliance with nasdaq listing requirements 06/28/2023
Creative medical technology announces $2 million share repurchase program 06/12/2023
Creative medical technology holdings provides corporate update 06/12/2023
Creative medical technology holdings announces reverse stock split 06/09/2023
Creative medical technology holdings announces successful completion of the first phase of its program with greenstone biosciences, inc. to develop next generation ipsc pipeline for immcelz® immunotherapy platform 05/31/2023
Creative medical technology holdings announces next milestone achievements in immcelz® platform development 05/22/2023
Creative medical technology holdings announces positive top-line study results for chronic lower back pain utilizing its stemspine® procedure using allostem™ allogenic cell line 05/18/2023
Creative medical technology holdings announces filing of 2022 form 10-k and provides business update 04/04/2023
Creative medical technology files orphan drug designation application with the u.s. fda using the immcelz® platform for the treatment of brittle type 1 diabetes 03/23/2023
Creative medical technology holdings announces key milestones regarding immcelz® platform development 03/21/2023
Creative medical technology holdings engages highly respected international cro for phase 1 / 2 clinical trial to treat type 1 diabetes using celz-201 03/07/2023
Creative medical technology holdings announces irb approval for fda cleared phase 1/2 clinical trial of novel cell therapy for the treatment of type 1 diabetes 02/08/2023
Creative medical technology holdings announces fda clearance of investigational new drug (ind) application for allostem™, a novel cell therapy for the treatment of type 1 diabetes 11/03/2022
Creative medical technology holdings develops allostem™ clinical cell line 10/20/2022
Creative medical technology announces positive top-line results for ovastem® pilot study 07/28/2022
Creative medical technology holdings announces agreement with greenstone biosciences, inc. for development of a next generation ipsc pipeline for its immcelz® immunotherapy platform 06/15/2022
Creative medical technology announces $17 million private placement priced at-the-market under nasdaq rules 04/29/2022
Creative medical technology announces positive top-line results for stemspine® pilot study 03/23/2022
Creative medical technology to participate in the 34th annual roth conference 03/08/2022
Creative medical technology appoints sahil nock as chief commercial officer 03/02/2022
Creative medical technology holdings, inc. prices $16 million public offering and uplisting to the nasdaq capital market 12/03/2021

More Headlines

News
Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™ PHOENIX, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a pioneering biotechnology firm specializing in regenerative medicine solutions for immunotherapy, endocrinology, urology, gynecology, and orthopedics, today announced compelling mid-term follow-up data from its StemSpine® pilot study utilizing its AlloStem™ cells for the treatment of chronic lower back pain. The pilot study demonstrated a substantial reduction in opioid dependency and significant improvements in pain levels and functional mobility. 02/14/2025
Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program Significant Efficacy and No Serious Adverse Effects Observed with CELZ-201 Significant Efficacy and No Serious Adverse Effects Observed with CELZ-201 02/11/2025
Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development PHOENIX, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical”), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced an expanded agreement with Greenstone Biosciences Inc. (“Greenstone”) to leverage Artificial Intelligence (AI) in further developing its human induced pluripotent stem cell (iPSC) platform for diabetes treatment. 02/05/2025
Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain PHOENIX, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company focused on regenerative medicine, today announced promising initial data from the first cohort of its ongoing Phase 1/2 clinical trial of CELZ-201-DDT, the Company's proprietary stem cell-based therapeutic for the treatment of chronic back pain caused by degenerative disc disease (DDD). 01/30/2025
Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment PHOENIX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology leader in regenerative medicine, is pleased to announce the successful completion of an independent interim safety review by the Data Safety Monitoring Board (DSMB) for its ADAPT clinical trial. The trial evaluated CELZ-201, a novel therapeutic perinatal tissue derived cell product, designed to treat chronic lower back pain associated with degenerative disc disease. 11/13/2024
Creative Medical Technology Holdings Initiates Development of AI-Driven Diagnostic and Treatment Program for Biologic and Chemical Exposure Utilizing its Validated iPSC Personalized Medicine Program PHOENIX, July 24, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial-stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced that it has initiated its planned program to diagnose and treat patients exposed to biological and chemical weapons by combining Artificial Intelligence (AI) with the Company's proprietary human induced pluripotent stem cells (“iPSC”). This iPSC clinical line is part of the Company's iPSCelz® program. 07/24/2024
Creative Medical Technology Holdings Provides Corporate Update PHOENIX, July 10, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, today provided a corporate update highlighting recent developments of note. 07/10/2024
Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin PHOENIX, June 24, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced that it has successfully generated human induced pluripotent stem cells (iPSC)-derived Islet Cells that produce human insulin. 06/24/2024
Creative Medical Technology Holdings Provides Corporate Update PHOENIX--(BUSINESS WIRE)--Creative Medical Technology Holdings, Inc., (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, today provided a corporate update in connection with the filing of its Form 10-K on March 22, 2024. “In the past year our achievements have been some of the most consequential in the history of Creative Medical Technology,” said Timot. 03/27/2024
Creative Medical (CELZ) Up on Orphan Drug Tag for CELZ-101 Creative Medical's (CELZ) CELZ-101 gets FDA's Orphan Drug designation for preventing allograft rejection in type-I diabetes patients undergoing pancreatic islet cell transplantation. Stock rises. 03/07/2024
Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access PHOENIX--(BUSINESS WIRE)--Creative Medical Technology Holdings, Inc., (NASDAQ:CELZ), a leader in biotech innovation, today announced a major stride in combating Type 1 Diabetes Mellitus (T1D). The company has secured FDA authorization for an expanded access therapy using CELZ-201, a pioneering cell-based program in managing abnormal glucose tolerance and preventing T1D in high-risk individuals. This groundbreaking therapy uses CELZ-201 to potentially prevent T1D onset and is believed to be a fi. 03/07/2024
Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy PHOENIX--(BUSINESS WIRE)--Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a leader in the field of regenerative medicine with a focus on developing novel therapies in immunotherapy, endocrinology, urology, gynecology, and orthopedics, is pleased to announce the successful receipt of Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for CELZ-101, ImmCelzTM. This cutting-edge therapy is aimed at preventing allograft rejection in patients undergoing pancreatic isl. 03/06/2024
Creative Medical Technology Granted FDA Clearance for Chronic Back Pain Clinical Trial New York, December 21, 2023 – Creative Medical Technology Holdings, Inc. (Nasdaq: CELZ) has received FDA clearance to conduct a phase 1/2 clinical trial using the company's innovative StemSpine® treatment known as AlloStem™ (CELZ-201-DDT). 12/21/2023
Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain PHOENIX, AZ / ACCESSWIRE / December 20, 2023 / Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ), a biotechnology company has received clearance from the FDA to conduct a phase 1/2 clinical trial using their innovative StemSpine® treatment known as AlloStem™. This study aims to determine the safety, efficacy and tolerability of CELZ-201-DDT, a proprietary, ready-to-use cell line developed by the company. 12/20/2023
Creative Medical Technology Holdings Provides Corporate Update Continuing to Advance Regenerative Therapies for Diabetes and Chronic Lower Back Pain Strong Financial Position with No Long-Term Debt PHOENIX , Nov. 15, 2023 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, today provided an update on recent business activities in connection with the filing of its Form 10-Q with the Securities and Exchange Commission. "We continue to make progress developing our regenerative therapeutics, building important assets, and managing a robust product pipeline, while maintaining a strong financial position," said Timothy Warbington, Chief Executive Officer of Creative Medical Technology. 11/15/2023
Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain Company reaches next clinical trial milestone for the intramuscular treatment of Chronic Lower Back Pain with the first novel allogenic cellular therapy in the United States PHOENIX , Oct. 10, 2023 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, today announced that it has received Institutional Review Board ("IRB") approval to proceed with its clinical trial for the treatment of chronic lower back pain with its StemSpine® procedure using AlloStem™ ("CELZ-201-DDT") cell therapy. The receipt of IRB approval is a necessary step that will allow Creative Medical Technology to move forward with recruitment of its recently FDA approved Phase 1 /2 randomized, double blind, placebo controlled clinical trial to evaluate the safety, efficacy, and tolerability of CELZ-201-DDT. 10/10/2023
What Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stock Creative Medical Technology Holdings, Inc. (CELZ) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. 09/22/2023
Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain PHOENIX , Sept. 19, 2023 /PRNewswire/ -- Creative Medical Technology Holdings, Inc. ("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, gynecology, and orthopedics, today announced that the U.S. Food and Drug Administration ("FDA") has cleared the Company to proceed with a Phase 1/2 clinical trial of StemSpine® using AlloStem™ ("CELZ-201-DDT"). 09/19/2023
What Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth? PHOENIX, AZ / ACCESSWIRE / August 24, 2023 / Biotechnology company Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) seems to be witnessing success in the allogeneic cell therapy market. In Q4 2022, the company - best known for its regenerative approach to immunotherapy, endocrinology, urology, gynecology and orthopedics - made a significant announcement regarding the successful development of an allogeneic cell line known as AlloStem™. 08/24/2023
The Immunotherapy Market is Expected to Surpass $351.56 Billion by 2030 - Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) is Contributing to this Growth PHOENIX, AZ / ACCESSWIRE / July 14, 2023 / Immunotherapy, in general, is an exciting and growing sector in the pharmaceutical industry. It involves manipulating the human body's immune system to treat various diseases. 07/14/2023
Creative Medical Technology Reports Advancements In Regenerative Medicine And Improvements In Financial Position In Corporate Update PHOENIX, AZ / ACCESSWIRE / July 13, 2023 / Creative Medical Technology Holdings, Inc. ("Creative Medical Technology") (NASDAQ:CELZ) recently released an update on their drug pipeline and financial standing going into Q3 2023. The biotechnology company is known for its regenerative approach to immunotherapy, endocrinology, urology, gynecology and orthopedics. 07/13/2023
Creative Medical (CELZ) Up 86% on Upbeat Diabetes Study Data Creative Medical Technology (CELZ) reports positive one-year follow-up data from a study showing the efficacy of CELZ-001 in treating type II diabetes without any serious adverse effects. 04/13/2023
3 Methods for Finding Penny Stocks to Buy and Hold Use these strategies for making money with penny stocks in 2023 The post 3 Methods for Finding Penny Stocks to Buy and Hold appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 04/13/2023
Creative Medical Technology Holdings Engages Highly Respected International CRO for Phase 1 / 2 Clinical Trial to Treat Type 1 Diabetes Using CELZ-201 PHOENIX--(BUSINESS WIRE)--Creative Medical Technology Holdings, Inc. 03/07/2023
Why Is Creative Medical (CELZ) Stock Up 121% Today? Creative Medical (NASDAQ: CELZ ) stock is rocketing higher on Wednesday thanks to clearance for a new clinical trial. That clearance comes from the FDA and covers CELZ-201 cell therapy. 02/08/2023
Penny Stocks To Buy Now? 5 To Watch After News This Week Stock Market News Has These Penny Stocks On Traders' Watch Lists This Week. The post Penny Stocks To Buy Now? 02/08/2023
Penny Stocks to Watch as June Comes to an End Are these penny stocks on your watchlist right now? The post Penny Stocks to Watch as June Comes to an End appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 06/30/2022
Penny Stocks To Buy? 8 Short Squeeze Stocks To Watch Now Short squeeze penny stocks to watch. The post Penny Stocks To Buy? 04/21/2022
Best Penny Stocks To Buy Now? 5 Short Squeeze Stocks To Watch Short squeeze penny stocks to watch right now. The post Best Penny Stocks To Buy Now? 04/20/2022
Trending Penny Stocks to Buy Now, 3 to Watch During Trading in April Check these three trending penny stocks out for your watchlist right now The post Trending Penny Stocks to Buy Now, 3 to Watch During Trading in April appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 03/31/2022
Best Penny Stocks to Buy as March Ends? 3 For Your List Are these penny stocks on your April watchlist? The post Best Penny Stocks to Buy as March Ends? 03/28/2022
How to Trade Penny Stocks in April 2022 and 3 to Watch Here's what you need to know about trading penny stocks in April The post How to Trade Penny Stocks in April 2022 and 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 03/27/2022
Top Must-Watch Penny Stocks For Your April List Are these penny stocks on your April watchlist? The post Top Must-Watch Penny Stocks For Your April List appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 03/25/2022
Creative Medical (CELZ) Up 82% on Stem Cell Treatment Data Creative Medical Technology (CELZ) reports positive follow-up data from a pilot study evaluating StemSpine, a patented stem cell treatment for chronic lower back pain. 03/24/2022
Why Is Creative Medical Technology (CELZ) Stock Up Today? Creative Medical Technology announced positive results concerning its StemSpine procedure. Here's what you should know as CELZ stock rises. 03/23/2022
Why Creative Medical Technology Shares Are Soaring Creative Medical Technology Holdings Inc (NASDAQ: CELZ) shares are trading higher Wednesday after the company announced top-line results for its follow-up StemSpine pilot study. The initial study showed significant efficacy of the StemSpine procedure for treating chronic lower back. 03/23/2022
Creative Medical Shares Soar On Positive Data from StemSpine Pilot Study Creative Medical Technology Holdings (NASDAQ: CELZ) has announced positive two-year follow-up data from its StemSpine pilot study. 03/23/2022
Trading Penny Stocks? Top Stock Market News For March 23rd, 2022 Here's what you need to know about trading penny stocks on March 23rd The post Trading Penny Stocks? Top Stock Market News For March 23rd, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 03/23/2022
Best Penny Stocks To Buy? 8 Low Float Stocks To Watch Right Now Low float penny stocks to add to your watch list right now. The post Best Penny Stocks To Buy? 02/18/2022
Trading Penny Stocks? Top Stock Market News for February 18th, 2022 Here's what you need to know about trading penny stocks today The post Trading Penny Stocks? Top Stock Market News for February 18th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 02/18/2022
4 Low Float Penny Stocks To Watch After ISPO Stock Explodes Low float penny stocks to watch right now. The post 4 Low Float Penny Stocks To Watch After ISPO Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 02/17/2022
4 Top Penny Stocks To Watch For A Short Squeeze Short squeeze penny stocks to watch The post 4 Top Penny Stocks To Watch For A Short Squeeze appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 01/14/2022
7 Short Squeeze Penny Stocks To Buy For Under $5 Right Now Short squeeze penny stocks to watch right now. The post 7 Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 01/11/2022
Short Squeeze Penny Stocks To Buy Now? 4 To Watch Under $5 Will these penny stocks see a short squeeze this week? The post Short Squeeze Penny Stocks To Buy Now? 01/10/2022
Best Reddit Penny Stocks To Buy Now? 5 Trending Stocks To Watch Today What are the best penny stocks to buy today? The post Best Reddit Penny Stocks To Buy Now? 01/07/2022
8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE We're diving into the top penny stocks to watch today as several names in the space see major movement on Monday alongside heavy trading. The post 8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE appeared first on InvestorPlace. 01/03/2022
CELZ Stock: 5 Things to Know About Trending Penny Stock Creative Medical Technology Creative Medical Technology (CELZ) stock is taking off on Monday despite a lack of news from the commercial-stage biotechnology company. The post CELZ Stock: 5 Things to Know About Trending Penny Stock Creative Medical Technology appeared first on InvestorPlace. 01/03/2022
Best Penny Stocks to Buy Today? 3 For Your Watchlist in January Are these penny stocks on your watchlist right now? The post Best Penny Stocks to Buy Today? 01/03/2022
Creative Medical Technology Stock (CELZ): Why The Price Surged Today The stock price of Creative Medical Technology Holdings Inc (NASDAQ: CELZ) increased by over 50% pre-market today. This is why it happened. 01/03/2022
Low Float Penny Stocks To Buy For Under $5 After RELI Surges 250% Low float penny stocks to add to your watch list this week The post Low Float Penny Stocks To Buy For Under $5 After RELI Surges 250% appeared first on Penny Stocks to Buy, Picks, News and Information \| PennyStocks.com. 12/28/2021

Unlock

CELZ Ratings Summary

CELZ Quant Ranking